FEATURED ARTICLES

• Patient-Reported Outcome In Oncology Clinical Trials

  As cancer therapies grow more complex and personalized, patient-reported outcomes (PROs) have emerged as a vital component of oncology research and care.

• Navigating The 7 Biggest Challenges In Rare Disease Clinical Trials

  Discover how partnering with specialized rare disease CROs allows drug sponsors to accelerate treatment development, navigate trial complexities, and ultimately improve patient outcomes.

• Reimagining Medical Monitoring In Clinical Research

  Clinical trials are undergoing a transformative shift driven by evolving regulations, advanced technologies, and decentralized methodologies.

• The New Era Of Medical Monitoring

  Examine the transformative landscape of medical monitoring in clinical trials with an emphasis on the shift from conventional retrospective reviews to a proactive, risk-based methodology.

• Key Strategies For Clinical Development In Rare Cancers

  Successful execution of rare cancer clinical trials requires strategic patient recruitment, innovative trial design, and specialized expertise from Oncology CROs.

• Innovative Approaches In Oncology Clinical Trials

  By embracing innovative trial models and strategic collaborations, oncology CROs play a pivotal role in bringing novel cancer therapies to market efficiently and effectively.

• 6 Strategies To Engage Rare Disease PAOs Effectively

  Patient advocacy organizations (PAOs) play a pivotal role in rare disease research by bridging the gap between patient communities and biotech companies.

• Tips And Tricks For Developing Rare Cancer Clinical Trials

  Conducting clinical trials for rare cancers presents unique challenges, making a partnership with an experienced Oncology CRO crucial for overcoming hurdles and ensuring trial success.